UNSPSC 51171522: Calcium lactate

This classification denotes a nutritional supplement with the molecular formula 2C3H5O3.Ca, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2URQ2N32W3, chemically known as propanoic acid, 2-hydroxy-, calcium salt (2:1) but generally known as calcium lactate, which bears US NIH Compound Identifier 13144. European Medicines Agency schedules Calcium lactate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB13184MIG.

UNSPSC 51171522 Calcium lactate (Commodity) does not correspond meaningfully to the recent state and local procurement activity posted under this code. The three most recent opportunities — offender drug testing services from Collin County, a therapeutic pharmacy initiative RFI from Texas HHS, and a multistate cooperative pharmaceutical RFP from MMCAP — involve laboratory testing, pharmacy benefit management, and generic pharmaceutical distribution, none of which center on calcium lactate as a product or service input. The code appears to be a mislabeling artifact in state and local procurement systems, and no substantive recent market activity for calcium lactate itself is evident from the source.

The disconnect between the code designation and the actual procurement content limits the utility of this UNSPSC for vendor evaluation. Firms supplying calcium lactate directly to state or local buyers should monitor procurement activity under broader pharmaceutical ingredient or chemical supply codes rather than rely on this commodity designation. The opportunities listed under 51171522 do not represent acquisition pathways for calcium lactate suppliers.